-
Kulusevski return can spark Spurs: De Zerbi
-
Mbappe ends Nike partnership to join Swiss brand On
-
Shakira to cap off world tour with Madrid 12-gig run
-
Liverpool boss Iraola puts Bournemouth love affair on hold
-
Isolated Syrian-Druze city blames Damascus for shortages
-
'A disaster' if Man City do not win says Maresca after flawless start
-
Isolated Syrian-Druze city shortages
-
Kerry James Marshall: American 'blackness' painter celebrated in Europe
-
Dutch drop Depay for Germany match in Xavi's first pick
-
Spain coach De la Fuente offers 'full support' to people of Ceuta
-
Ronaldo named in Portugal squad for Nations League
-
Russia seizes assets of Nestle, French firms over West's Ukraine support
-
Stock markets diverge after central bank rate hikes
-
England can build on World Cup 'spirit', says Tuchel
-
Anti-Assad music star makes triumphant return to Syria
-
UNESCO can be 'moderator' in AI debate: chief to AFP
-
In-form Fernandez included in Spain Nations League squad
-
Infantino 'must go', says German FA vice-president
-
Arteta buries hatchet with Hurzeler ahead of Brighton clash
-
Russia seizes assets of Nestle, French firms
-
Alexander-Arnold and Palmer return to England squad for Nations League
-
Japan's busiest rail station tests robot bins
-
Russians vote as Ukraine war drags on for fifth year
-
Anthropic says AI systems moving towards building themselves
-
Backpackers fret over Australian visa crackdown
-
Asian stocks boosted by falling oil, yen weakens after BoJ rate hike
-
Most Asian stocks track Wall St rally, yen drops after BoJ rate hike
-
Pakistan court blocks expulsion of Afghan medical college students
-
Russians begin voting in controlled election as war drags on
-
Athletes 'can't take it any more' as Asian Games issues mount
-
Trump 'clearly' wants dialogue with Pyongyang: South Korean President
-
Allen lights up Bills' new stadium with 41-31 win over Lions
-
Bank of Japan hikes rates to 31-year high to battle inflation
-
Afghan medical students in Pakistan hope court stops college expulsions
-
Thailand's Muslim separatists vow to fight to the end
-
AI doomsday warnings unlikely to slow IPOs but questions linger
-
Mideast turmoil, AI set to dominate UN gathering of world leaders
-
ICC eyes China in bid to expand cricket
-
Australia to detain tourists who overstay visa, minister says
-
Nkunku craving freedom and fun on RB Leipzig return
-
Championship rivals brace for renewal of bitter feuds
-
Bhutan's traditional archers lose ground to development
-
In Brazil's Amazon, the hunt for oil fuels hopes and fears
-
Asian stocks track Wall St rally as oil prices drop
-
Australian athlete who soiled herself apologises for continuing Hyrox race
-
South Korea makes Asian Games complaint over Japan warlord ceremony
-
Baby orangutans in India expose 'frightening' scale of trafficking
-
US aid cuts are killing Kenyan sex workers
-
Doom Loop? Ed Sheeran struggles against Gaza tide
-
October 7 survivors, families take centre stage in Israel vote
StrainScan Pro Demonstrates Versatility as MDCE Applies Core AI Vision Technology Across Regulated Retail and Large-Scale Agriculture (OTCID:MDCE)
Proprietary Platform Highlights the Strength of a Single AI Vision System Serving Multiple Trillion Dollar Industries
MESA, AZ / ACCESS Newswire / August 26, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today emphasized the cross-industry versatility of its StrainScan Pro platform, underscoring how a single proprietary AI vision system is being applied across both regulated retail environments and large-scale agricultural operations.

StrainScan Pro is designed to deliver consistent visual analysis capabilities that support quality verification for licensed retail operators while also addressing agricultural needs such as early detection of pests, crop stress, and quality indicators. By leveraging the same core computer-vision architecture across these distinct sectors, the platform demonstrates the flexibility of Medical Care Technologies' AI vision approach.
The software remains optimized for deployment on iPad Air devices, allowing operators in both retail and agricultural settings to utilize a uniform, portable enterprise solution. This shared foundation enables the Company to advance one proprietary system rather than developing fragmented tools for each vertical.
"The true strength of StrainScan Pro lies in its ability to serve more than one industry with the same underlying technology," said Marshall Perkins, CEO of Medical Care Technologies. "Whether supporting visual quality verification in regulated retail or assisting with crop and field-level analysis in agriculture, we are focused on delivering a versatile AI vision platform that creates value across multiple large-scale markets."
Medical Care Technologies is a technology company. It develops and commercializes AI vision software and does not cultivate, process, distribute, or sell cannabis or any plant products.
By applying its core technology across multi-billion-dollar retail sectors and the multi-trillion-dollar global agriculture market, Medical Care Technologies continues to position StrainScan Pro as a flexible enterprise platform with broad commercial relevance.
Investors and industry participants can explore the platform at:
https://strainscanpro.com
Medical Care Technologies continues to advance its AI vision capabilities across high-value verticals while generating revenue through its operating subsidiaries.
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. Visit: https://medicalcaretechnologies.com
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.
Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: [email protected]
Websites: https://medicalcaretechnologies.com | https://strainscanpro.com
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
E.Flores--AT